After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, HALO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Halozyme Therapeutics Inc is $8.07B. A total of 1.85 million shares were traded on the day, compared to an average of 2.16M shares.
In the most recent transaction, Torley Helen sold 20,000 shares of HALO for 64.32 per share on Aug 13 ’25. After the transaction, the PRESIDENT AND CEO now owns 733,719 company shares. In a previous transaction on Aug 12 ’25, Torley Helen sold 20,000 shares at 63.51 per share. HALO shares that PRESIDENT AND CEO owns now total 733,719.
Among the insiders who sold shares, Torley Helen disposed of 20,000 shares on Aug 11 ’25 at a per-share price of $63.05. This resulted in the PRESIDENT AND CEO holding 733,719 shares of HALO after the transaction. In another insider transaction, Torley Helen sold 20,000 shares at $57.43 per share on Jul 10 ’25. Company shares held by the PRESIDENT AND CEO now total 733,719.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, HALO has a high of $70.50 and a low of $42.01.
As of this writing, HALO has an earnings estimate of $1.61 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $1.68 per share and a lower estimate of $1.48. The company reported an EPS of $1.27 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $2.83, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 3.55.
